Koning (2022)

Koning (2022)

About this raise

Koning, with a valuation of $230 million, is raising funds on StartEngine. The company has developed a revolutionary breast imaging technology that offers real isotropic 3D imaging. The Koning Breast CT creates high-contrast 3D breast images with high spatial resolution without the painful compression of mammograms. Koning has received approvals from FDA PMA, CFDA, CE Mark, and other global regulators and is designed for highly accurate early detection of breast cancer. Dr. Ruola Ning founded Koning in January 2002. The current crowdfunding campaign has a minimum target of $9,997.33 and a maximum target of $2,898,855.85. The campaign proceeds will be used for growth and expansion.

Expand

Investment Overview

Invested this round: $583,204

Deal Terms

Total Commitments

Platform
StartEngine
Start Date
08/01/2022
Close Date
12/30/2022
Min. Goal
$9,997
Max Goal
$2,898,856
Min. Investment

$489

Security Type

Equity - Common

Company Stage

Growth Stage

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$5.69

Pre-Money Valuation

$230,180,296

Company & Team

Company

Year Founded
2002
Industry
Healthcare & Pharmaceuticals
Tech Sector
Medtech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
Location
Norcross, Georgia
Business Type
Growth
Company Website
Visit Website

Team

Employees
14
Prior Founder Exits?
No
Founder Name
Ruola Ning
Title
Chairman & Founder

Financials

 Revenue +133% YoY
$7,200,000
 Monthly Burn
$405,789
 Runway
1.3 months
 Gross Margin
57%

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$357,779

$3,089,624

COGS

$153,022

$417,340

Tax

$65

$5,085

 

 

Net Income

$-4,869,465

$-1,135,429

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$522,412

$1,099,408

Accounts Receivable

$322,892

$777,636

Total Assets

$26,507,126

$27,843,270

Short-Term Debt

$3,768,501

$4,358,049

Long-Term Debt

$5,355,334

$5,198,730

Total Liabilities

$9,123,835

$9,556,779

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Analyst Report Analyst Report Methodology Article

Koning's machines can reliably detect stage 0 and stage 1 cancers. Just how significant is this? Detecting breast cancer at stages 0 or 1 gives patients a 99% five-year survival rate. Its imaging technology can also detect small calcifications and small tumors in patients with small or dense breasts -- something current mammograms struggle with. Calcifications, by the way, are often an early indicator of breast disease.

This changes the game. Mammography has ruled the industry for 60 years. While flawed, it was -- for its time -- the best technology available. That's no longer the case. 

Company Funding & Growth

Funding history

Total Prior Capital Raised
$2,101,141
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
12/30/2022 StartEngine $230,180,296 $583,204 Equity - Common Funded RegCF
01/18/2022 Republic $200,000,000 $2,135,386 SAFE Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.

Growth Charts

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Koning on StartEngine 2022
Platform: StartEngine
Security Type: Equity - Common
Valuation: $230,180,296
Price per Share: $5.69

Follow company

Follow Koning on StartEngine 2022

Buy Koning's Deal Report

Warning: according to the close date for this deal, Koning may no longer be accepting investments.

Koning Deal Report

Get Kingscrowd's comprehensive report on Koning including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Koning is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise
  • Our deep-dive analyst report reviewing the deal's investment potential and bullish vs. bearish outlook

Buy the Koning deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge